Kheraldine, H., Hassan, A. F., Saeed, S., Merhi, M., Mateo, J. M., Ulamec, M., . . . Moustafa, A. A. (2025). Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer.
Chicago Style (17th ed.) CitationKheraldine, Hadeel, et al. Neratinib and Metformin: A Novel Therapeutic Approach Against HER2-Positive Breast Cancer. 2025.
MLA (9th ed.) CitationKheraldine, Hadeel, et al. Neratinib and Metformin: A Novel Therapeutic Approach Against HER2-Positive Breast Cancer. 2025.
Warning: These citations may not always be 100% accurate.